Savvari, P.
Skiadas, I.
Papadakis, S. A.
Psychogios, V.
Argyropoulou, O. D.
Pastroudis, A. P.
Skarpas, G. A.
Tsoutsanis, A.
Garofalakis, A.
Katsifis, G.
Boumpas, D.
Menegas, D.
Article History
Received: 5 December 2022
Accepted: 1 August 2023
First Online: 15 August 2023
Declarations
:
: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and Guidelines for Good Epidemiological Practices (GPP) and was approved by the respective institutional review boards (IRBs) at all participating sites. The corresponding IRBs were: Board of Directors "Laiko" General Hospital of Athens, Board of Directors of Attikon University General Hospital, Scientific Board -Ethics Committee of Naval Hospital of Athens, Scientific Board of Asklipieio General Hospital of Voula, Scientific Board of MITERA Private Hospital, Scientific Board of General Hospital of Attica KAT. Informed consent was obtained from all subjects.
: Not applicable.
: P.Savvari, I.Skiadas and D.Menegas are currently Pfizer employees<b>.</b> Stamatios A Papadakis, Vasilis Psychogios, Ourania D. Argyropoulou, Alexandros P. Pastroudis, George A. Skarpas, Athanasios Tsoutsanis, Andreas Garofalakis, Gikas Katsifis, Dimitrios Boumpas have no competing interest.